Every investigation we've published, newest first — each one built on primary documents and classified under our evidence standard.
The case against Growth Cave didn't end when the operation was shut down — regulators kept investigating, and found two more people to add to the complaint months later.
Read the full report →The shoes were marketed to relieve knee, back, and joint pain. The company had already promised regulators once that it would stop making those claims without evidence. It didn't.
Read the full report →A cremation broker misrepresented where services would take place and what they would cost. Regulators say that when grieving families objected, the company refused to release their loved ones' remains until they paid.
Read the full report →Consumers thought they were financing a water softener. The FTC says some ended up with liens and debt terms so distorted they couldn't sell their own homes without addressing the company's financing first.
Read the full report →Names like American Consumer Rights Organization and Consumer Protection Resources sounded like independent watchdogs. Regulators say they were the same debt-relief operation, charging fees consumers were told would be part of their forgiven debt.
Read the full report →Alexander Beckman told investors his AI sports-chatbot company was landing major partnerships and turning a profit. The SEC says the supporting financial documents and audit reports were fabricated from the ground up.
Read the full report →The Supreme Court rejected the deal that would have shielded the Sackler family from lawsuits. The new agreement costs $1.4 billion more, strips the Sacklers of the company entirely, and still won't erase what OxyContin's marketing did.
Read the full report →Three companies promised to free Minnesotans from costly timeshare contracts. The state's Attorney General found none of them had the licenses state law requires — and all three charged big fees upfront anyway.
Read the full report →The company collected personal data from young players without notifying parents. Regulators say it kept doing so even after learning, in specific cases, that the players it was tracking were children.
Read the full report →A New York Times investigation found GM was selling detailed driving behavior data to insurance-adjacent data brokers. The FTC's resulting case bans GM from sharing that data for five years and demands consumer consent for two decades.
Read the full report →Shoppers see a 'verified' badge on a review and assume it means the platform confirmed a real purchase happened. Regulators say that assumption often wasn't true on Sitejabber.
Read the full report →Stem cell therapy sounds like cutting-edge medicine. Regulators say this company marketed it as a proven treatment for serious diseases anyway — without the clinical evidence federal law requires before making that claim.
Read the full report →